LENZ Therapeutics (NASDAQ:LENZ - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.41) per share for the quarter.
LENZ Therapeutics Price Performance
NASDAQ LENZ traded down $1.45 on Friday, hitting $23.49. The stock had a trading volume of 113,960 shares, compared to its average volume of 94,453. The business's fifty day moving average price is $26.54 and its 200 day moving average price is $26.96. LENZ Therapeutics has a 52-week low of $14.42 and a 52-week high of $38.93.
Analysts Set New Price Targets
Separately, HC Wainwright restated a "buy" rating and set a $38.00 target price on shares of LENZ Therapeutics in a research note on Thursday, November 7th. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $35.40.
Read Our Latest Analysis on LENZ Therapeutics
LENZ Therapeutics Company Profile
(
Get Free Report)
LENZ Therapeutics, Inc, a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Read More
Before you consider LENZ Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LENZ Therapeutics wasn't on the list.
While LENZ Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
